Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.
Firinu D, Perra A, Campagna M, Littera R, Fenu G, Meloni F, Cipri S, Sedda F, Conti M, Miglianti M, Costanzo G, Secci M, Usai G, Carta MG, Cappai R, Orrù G, Del Giacco S, Coghe F, Chessa L.
Firinu D, et al. Among authors: secci m.
Clin Exp Med. 2022 Aug;22(3):477-485. doi: 10.1007/s10238-021-00771-3. Epub 2021 Nov 5.
Clin Exp Med. 2022.
PMID: 34741188
Free PMC article.